fda ods approved, page-23

McCoy you may want to read that again.

No mention of approval at that stage.

"Outlook for the next 12 months

The upcoming 12 months promises to be another
period of rapid development for the Company, with
the progression of the late stage trials for CVac
being a key priority and focus. The following is an
overview of some of the key milestone points to
look out for during this period.

Orphan Drug status for CVac with FDA and
Fast Track Application for CVac with FDA.
Both these represent significant points in the
development of CVac and will help ensure that
the commercialisation of CVac is achieved in a
timely and efficient manner. The Company hopes
to secure FDA Orphan Drug status for CVac? and
also submit its Fast Track Application for CVac?
with the FDA by the end of 2010."